Re: Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Texbraska

Rank: Mail Room [?]

Points: 247 [?]

Votes: 9 Score: 4.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment

in response to

Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment

10BagR

posted on Jan 18, 2022 08:24AM

"Adaptations have been made to the trial to expedite full enrollment..."

Impressed with this line. Others here speculated that Omicron limited the trial due to patients not suffering the same severity of symptoms as previous variants. If RVX was able to pivot with adaptations to the trial this quickly (comparatively!) I think they deserve credit.

Hope they start getting amazing results.

GLTA

8 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply